By Business & Finance 
Pictured: Lorraine Ivory-Corr, Senior Broker Consultant, Royal London Ireland
This week sees new and notable appointments at Royal London Ireland, Ipsen, Suir Engineering, Vantiva, Avacta and Nokia.
Lorraine Ivory-Corr, Senior Broker Consultant,
Royal London Ireland
Royal London Ireland, a life insurance and pensions provider, announced the appointment of Lorraine Ivory-Corr as Senior Broker Consultant. With more than three decades in the industry, Lorraine will help grow its pension business, which launched to market in 2022, alongside its established protection offering.
Prior to taking this role, Lorraine spent nine years as an Account Manager at Aviva (previously Friends First before they merged). Before that, she served as a Premier Wealth Manager with the Bank of Ireland for over eight years. In her new role at Royal London Ireland, Lorraine will be responsible for fostering and strengthening broker relationships across the Southwest and Southeast of the country, including Cork, Waterford, and Wexford. Her focus will be on delivering tailored support and guidance to brokers in relation to both pensions and protection products.
Royal London Ireland, with a head office in Dublin, is a leading provider of life insurance and pension solutions and is a wholly owned subsidiary of The Royal London Mutual Society Limited.
Daragh Feely, Sales Director at Royal London Ireland, said:
“Lorraine’s extensive experience and deep understanding of the financial services industry will be invaluable in further strengthening our relationships with brokers across the Southwest and Southeast. As we look to grow and expand our pension offering in the market alongside our protection proposition, Lorraine’s experience brings a unique set of skills that will enhance the support and tailored solutions we offer Financial Brokers.”
Lorraine Ivory-Corr, Senior Broker Consultant at Royal London Ireland, said:
“I’m eager to collaborate with the talented team of Broker Consultants here and to closely engage with brokers in the Southwest and Southeast. My goal is to fully understand their challenges and aspirations, so I can provide them with meaningful support and guidance.”
Bénédicte Verley Hudry, Site Head of Dublin,
Ipsen
Ipsen, a biopharmaceutical company which specializes in oncology, rare diseases and neuroscience, appointed Bénédicte Verley Hudry as Site Head of Dublin. Bénédicte joined Ipsen in 2017, starting her career with the company as a Support Production Manager, based in Dreux. Since then, she held multiple roles in Ipsen’s Boulogne-Billancourt and Wrexham sites, including Head of Manufacturing 4.0. Over her 20-year career, Bénédicte has managed large manufacturing and packaging, engineering, and supply chain departments across several life science companies such as Arko Pharma, Ethypharm, OCP by Phoenix Group, Delpharm and Boiron.
Bénédicte holds a Doctor of Pharmacy (Pharm.D) from Université Paris Descartes and a Master’s in Biotechnology. She was also shortlisted for the Women in Pharma Award by the Pharma Industry Awards UK 2024, recognising the exceptional achievements of women who have made significant contributions to the pharmaceutical industry, through demonstrating leadership, innovation, and excellence in their roles.
Pierrick Lefranc, SVP Head of Global Manufacturing Operations at Ipsen said:
“I am delighted to announce Bénédicte as Site Head of Dublin. Bénédicte has a wealth of knowledge acquired from previous roles within the company, and I look forward to working closely with her as part of Ipsen’s Global Leadership Team. I wish her every success in her new role.”
Bénédicte Verley Hudry, Site Head of Dublin at Ipsen said:
“I am absolutely thrilled to be joining the team at Ipsen Ireland as Site Head of Dublin at such an exciting time for the company. Ipsen has built strong roots in Ireland, grounded in a commitment to excellence that is evidenced by each and every member of the team.”
Peter Browne, Head of Strategy,
Suir Engineering
Suir Engineering, one of Ireland’s engineering services providers, appointed Peter Browne as Head of Strategy. The move follows Peter Browne’s three-year tenure as Head of Strategy at specialist construction management company mac-group and, more recently, as Head of Business Development at Belfast-based construction company Portview. In total, Peter brings over 20 years of industry experience to this new role.
His role will focus on detailed market research and analysis, identifying new business opportunities and positioning the company for international market expansion and growth. Additionally, Peter will oversee the marketing and business development functions, ensuring focus on key clients and effective communication of the business proposition. He will also assess the viability of Suir Engineering’s new market expansion, working closely with the board and business unit directors to ensure the company is positioned to exploit the opportunities afforded by the growth in key market sectors both locally and internationally.
Headquartered in Waterford and with offices in Dublin, London, Manchester, Stockholm, Copenhagen and Frankfurt, Suir Engineering provides mechanical, electrical and instrumental engineering services in Europe. It operates in four core sectors: life sciences, energy, power and renewables, food and beverage and data centres.
Brendan Moley, Chief Operations Officer at Suir Engineering, said:
“Peter’s astute knowledge of business development and diverse skill set makes him an excellent addition to our growing team and integral to the growth of the business. As well as being a highly regarded professional in the industry, Peter has an instinct for innovation and a creative flair that I know helps shape and drive Suir Engineering’s long-term success both in Ireland and abroad in Europe.”
Peter Browne, Head of Strategy at Suir Engineering, said:
‘‘I’m thrilled to be working with one of the foremost engineering companies in Ireland and at a pivotal point in the company’s journey. The rapid pace of expansion in our key markets presents significant challenges and opportunities, and I’m very much looking forward to working with Suir Engineering’s team of industry experts and innovators to realise our growth ambitions.’’
Tim O’Loughlin, Chief Executive Officer,
Vantiva
Vantiva, a global technology company enabling network service providers to connect consumers worldwide, announces the appointment of Tim O’Loughlin as CEO. With over 20 years of corporate leadership experience, Tim brings significant expertise in strategic hardware and enterprise software technology markets. Most notably, he spent 18 years in senior leadership roles with two companies recently acquired by Vantiva: ARRIS and Pace. Since January 2, 2024, Tim has served as Senior Vice President of the Americas Customer Unit for Vantiva.
Tim O’Loughlin will operationalize the role from Vantiva’s offices in Paris, France, and Norcross, Georgia, USA.
Brian Shearer, Vantiva’s Chairman of the Board, said:
“Tim’s extensive experience across multiple technology verticals, executive management skills, and strong customer relationships developed throughout his career will strengthen the group’s position and be invaluable in leading Vantiva forward.”
Tim O’Loughlin, Chief Executive Officer at Vantiva, said:
“I am excited and humbled to have the opportunity to lead the incredible team at Vantiva. Our company is a portfolio of the best players and brands in the industry, and we will leverage that heritage of excellence and innovation to achieve great things. Every day, we put our customers at the center of our business – this will continue to drive us forward as a team.”
Michelle Morrow, Chief Scientific Officer, Avacta Group
Avacta Group plc, a life sciences company developing oncology drugs, announced the appointment of seasoned scientific leader Michelle Morrow, PhD as Chief Scientific Officer effective from November 4, 2024. Dr. Morrow brings nearly 20 years of experience in oncology therapeutics and antibody research at both biotech and pharmaceutical companies. She will fill a key role in the management team at Avacta as the Company evolves into a therapeutics-focused biotech.
She most recently served at invoX Pharma as Senior Vice President (SVP), Head of invoX Therapeutics Innovation, leading a discovery and preclinical research team that was established following the Company’s acquisition of F-star Therapeutics, where she held the position of SVP, Head of Research. During her time at F-star, Dr. Morrow made significant contributions to progressing bispecific candidates from discovery into clinical trials and led F-star’s biology and translational research functions. Prior to that, she established an immuno-oncology preclinical modelling group supporting projects across the Medimmune and AstraZeneca portfolio and held Discovery Project Leader roles for Imfinzi®, an approved anti-PD-L1 antibody, and volrustomig, an anti- PD-1/CTLA-4 bispecific antibody.
Christina Coughlin, MD, PhD, Chief Executive Officer of Avacta, said:
“We are thrilled to welcome Michelle to the team, she brings decades of experience in translating early science into innovative and effective medicines for patients… Michelle will be a significant asset to the Avacta team in driving our programs forward and we look forward to benefiting from her wealth of expertise.”
Michelle Morrow, PhD, Chief Scientific Officer designate of Avacta, said:
“I am delighted to join Avacta at such an exciting time in its development…I look forward to leveraging my experience in oncology drug development to help further drive the Company’s pipeline and explore the full potential of our therapies to benefit patients’ lives.”
Mikko Hautala, Chief Geopolitical and Government Relations Officer, Nokia
Nokia, announced the appointment of the Former Finland ambassador to the U.S. Mikko Hautala to Chief Geopolitical and Government Relations Officer and member of the Group Leadership Team, effective November 1, 2024. As the impact geopolitics has on Nokia’s business continues to grow, the company has taken the decision to establish the new role of Chief Geopolitical and Government Relations Officer. Mikko Hautala has been appointed to this role and will be based in Espoo, Finland, reporting to Pekka Lundmark.
Hautala as as Finland’s ambassador to the United States and to Russia, has over two decades of government experience in prominent roles across the world. He held a range of government roles, including foreign policy advisor to Finland’s former President Sauli Niinistö.
Pekka Lundmark, president and Chief Executive Officer of Nokia, said:
“Mikko’s vast experience, excellent networks and deep understanding of international diplomacy will be hugely valuable to Nokia as geopolitical factors and government policies increasingly shape our operating environment. I’m excited to welcome Mikko to the Nokia team and believe his unique strategic perspective will help strengthen our positioning in our key markets.”
Mikko Hautala, Chief Geopolitical and Government Relations Officer, said:
“I am extremely delighted to join Nokia’s leadership team at the moment when geopolitical and strategic considerations matter more than ever. Navigating the right path under these conditions is demanding, but offers great potential for sustainable business growth.”
Louise Fisk, Chief Communications Officer, Nokia
Nokia, announced the promotion of Louise Fisk to Chief Communications Officer, effective immediately. She will continue to be based in London, U.K. and report to Pekka Lundmark. Fisk’s previous role at Nokia was VP, Corporate Affairs Programs & Corporate Communications. Before joining Nokia, she worked in a number of senior leadership roles, including BAE Systems Applied Intelligence and Logica.
Pekka Lundmark, president and Chief Executive Officer of Nokia, said:
“I’m pleased to welcome Louise to our leadership team where she will further strengthen our strategic communications and brand positioning. Louise has already proven her ability to protect and enhance Nokia’s reputation and I look forward to her further developing our strategic positioning.”
Read More:
New and notable appointments at St. Vincent’s Healthcare Group, Matheson and Bank of Ireland Group
